NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/05/2025
Back to search
Official data from USPTO
ESPEROCT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
11/06/2025
Trademark type
Word
Nice classes
5
Filing date
07/24/2014
Registration date
03/10/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/05/2025
Last transaction
11/06/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Zürich, CH
Examiner
DESAI,BRIN ANDERSON
Current location
Historical data usage
Holders and representatives
Holders
Novo Nordisk Health Care AG
Novo Nordisk Health Care AG
Representatives
/Spencer Beall/ White & Case LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for hemostasis management
Publications
History of USPTO decisions and trademark events.
30 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
11/05/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/17/2025
PR71
POST REGISTRATION ACTION MAILED - SEC.71
03/31/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/11/2025
ES71
TEAS SECTION 71 RECEIVED
10/21/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/02/2024
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/04/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/06/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/20/2021
71AG
REGISTERED-SEC.71 ACCEPTED
01/19/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2021
ES71
TEAS SECTION 71 RECEIVED
09/30/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/05/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/20/2015
FIMP
FINAL DISPOSITION PROCESSED
05/20/2015
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
04/09/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2015
PUBO
PUBLISHED FOR OPPOSITION
12/23/2014
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/03/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/03/2014
NPUB
NOTICE OF PUBLICATION
12/03/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2014
DOCK
ASSIGNED TO EXAMINER
11/06/2014
MAFR
APPLICATION FILING RECEIPT MAILED
10/10/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/06/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/02/2014
Continuous trademark protection
Get notified about every new filing that threatens ESPEROCT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.